Breaking News Instant updates and real-time market news.

EME

Emcor

$116.85 /

-1.21 (-1.02%)

16:46
09/16/21
09/16
16:46
09/16/21
16:46

Emcor CEO sells 13,247 common shares

In a regulatory filing, Emcor chairman, president, and CEO Anthony Guzzi disclosed the sale of 13,247 common shares of the company on September 15 at a price of $118.038 per share.

EME Emcor
$116.85 /

-1.21 (-1.02%)

07/30/21 DA Davidson
Emcor price target raised to $125 from $115 at DA Davidson
06/24/21
Fly Intel: Top five analyst upgrades
06/24/21 KeyBanc
KeyBanc upgrades Emcor, says 'on the cusp' of sustained sales growth
06/24/21 KeyBanc
Emcor upgraded to Overweight from Sector Weight at KeyBanc

TODAY'S FREE FLY STORIES

Syndicate
The Real Good Food Company announces launch of initial public offering » 06:24
10/28/21
10/28
06:24
10/28/21
06:24
RGF

The Real Good Food Company

/

+

The Real Good Food…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
Xenon Pharmaceuticals initiated with an Outperform at RBC Capital » 06:24
10/28/21
10/28
06:24
10/28/21
06:24
XENE

Xenon Pharmaceuticals

$30.15 /

-0.47 (-1.53%)

RBC Capital analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$30.15 /

-0.47 (-1.53%)

XENE Xenon Pharmaceuticals
$30.15 /

-0.47 (-1.53%)

10/06/21 Wedbush
Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
10/04/21 Jefferies
Jefferies ups Xenon target to $50 after 'home run' epilepsy data
10/04/21 Guggenheim
Xenon Pharmaceuticals price target raised to $45 from $30 at Guggenheim
10/04/21 William Blair
Xenon's X-Tole data 'as good as it gets,' says William Blair
XENE Xenon Pharmaceuticals
$30.15 /

-0.47 (-1.53%)

  • 06
    Oct
  • 10
    Mar
XENE Xenon Pharmaceuticals
$30.15 /

-0.47 (-1.53%)

Earnings
Clarivate backs FY21 adjusted EPS view 70c-74c, consensus 70c » 06:24
10/28/21
10/28
06:24
10/28/21
06:24
CLVT

Clarivate

$22.22 /

-0.3 (-1.33%)

Backs FY21 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLVT Clarivate
$22.22 /

-0.3 (-1.33%)

CLVT Clarivate
$22.22 /

-0.3 (-1.33%)

08/16/21 BofA
BofA starts Clarivate at Buy on attractive valuation, predictable model
08/16/21 BofA
Clarivate initiated with a Buy at BofA
08/04/21 RBC Capital
Clarivate assumed with an Outperform at RBC Capital
06/25/21 Morgan Stanley
Clarivate 'the best short-term trade' in business services, says Morgan Stanley
CLVT Clarivate
$22.22 /

-0.3 (-1.33%)

  • 10
    Sep
  • 10
    Jun
CLVT Clarivate
$22.22 /

-0.3 (-1.33%)

Earnings
MiX Telematics reports Q2 non-GAAP EPS 10c, consensus 12c » 06:22
10/28/21
10/28
06:22
10/28/21
06:22
MIXT

MiX Telematics

$12.80 /

-0.2 (-1.54%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MIXT MiX Telematics
$12.80 /

-0.2 (-1.54%)

MIXT MiX Telematics
$12.80 /

-0.2 (-1.54%)

01/29/21 Canaccord
MiX Telematics price target raised to $19 from $16 at Canaccord
MIXT MiX Telematics
$12.80 /

-0.2 (-1.54%)

Upgrade
Teradyne upgraded to Outperform from Market Perform at Cowen » 06:22
10/28/21
10/28
06:22
10/28/21
06:22
TER

Teradyne

$123.07 /

+7.85 (+6.81%)

Cowen analyst Krish…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TER Teradyne
$123.07 /

+7.85 (+6.81%)

TER Teradyne
$123.07 /

+7.85 (+6.81%)

05:31 Today Cowen
Teradyne upgraded to Outperform from Market Perform at Cowen
10/27/21 Piper Sandler
Teradyne price target raised to $141 from $137 at Piper Sandler
10/14/21 Piper Sandler
Piper starts Teradyne at Overweight on robotics segment growth
10/14/21 Piper Sandler
Teradyne initiated with an Overweight at Piper Sandler
TER Teradyne
$123.07 /

+7.85 (+6.81%)

TER Teradyne
$123.07 /

+7.85 (+6.81%)

TER Teradyne
$123.07 /

+7.85 (+6.81%)

Initiation
Li Auto initiated with an Outperform at Bernstein » 06:21
10/28/21
10/28
06:21
10/28/21
06:21
LI

Li Auto

$32.65 /

-0.425 (-1.28%)

Bernstein analyst Eunice…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LI Li Auto
$32.65 /

-0.425 (-1.28%)

LI Li Auto
$32.65 /

-0.425 (-1.28%)

10/14/21 Nomura
Li Auto initiated with a Buy at Nomura
08/31/21 BofA
Li Auto price target raised to $42 from $39 at BofA
08/17/21 Citi
Li Auto price target lowered to $42.50 from $48.10 at Citi
08/12/21 Goldman Sachs
Li Auto H-shares initiated with a Conviction Buy at Goldman Sachs
LI Li Auto
$32.65 /

-0.425 (-1.28%)

  • 13
    Aug
  • 04
    Dec
LI Li Auto
$32.65 /

-0.425 (-1.28%)

LI Li Auto
$32.65 /

-0.425 (-1.28%)

LI Li Auto
$32.65 /

-0.425 (-1.28%)

Earnings
Clarivate reports Q3 adjusted EPS 16c, consensus 15c » 06:21
10/28/21
10/28
06:21
10/28/21
06:21
CLVT

Clarivate

$22.22 /

-0.3 (-1.33%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLVT Clarivate
$22.22 /

-0.3 (-1.33%)

CLVT Clarivate
$22.22 /

-0.3 (-1.33%)

08/16/21 BofA
BofA starts Clarivate at Buy on attractive valuation, predictable model
08/16/21 BofA
Clarivate initiated with a Buy at BofA
08/04/21 RBC Capital
Clarivate assumed with an Outperform at RBC Capital
06/25/21 Morgan Stanley
Clarivate 'the best short-term trade' in business services, says Morgan Stanley
CLVT Clarivate
$22.22 /

-0.3 (-1.33%)

  • 10
    Sep
  • 10
    Jun
CLVT Clarivate
$22.22 /

-0.3 (-1.33%)

Initiation
XPeng initiated with an Outperform at Bernstein » 06:21
10/28/21
10/28
06:21
10/28/21
06:21
XPEV

XPeng

$45.89 /

+0.56 (+1.24%)

Bernstein analyst Eunice…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XPEV XPeng
$45.89 /

+0.56 (+1.24%)

XPEV XPeng
$45.89 /

+0.56 (+1.24%)

10/14/21 Nomura
Li Auto initiated with a Buy at Nomura
10/01/21 BofA
XPeng price target raised to $63 from $61 at BofA
09/24/21 Citi
XPeng recent selloff a buying opportunity, says Citi
09/16/21 Morgan Stanley
XPeng 'aiming to redefine mass-market EVs' with P5, says Morgan Stanley
XPEV XPeng
$45.89 /

+0.56 (+1.24%)

  • 09
    Dec
XPEV XPeng
$45.89 /

+0.56 (+1.24%)

XPEV XPeng
$45.89 /

+0.56 (+1.24%)

XPEV XPeng
$45.89 /

+0.56 (+1.24%)

Recommendations
Wabtec price target lowered to $90 from $95 at Citi » 06:21
10/28/21
10/28
06:21
10/28/21
06:21
WAB

Wabtec

$88.87 /

-2.805 (-3.06%)

Citi analyst Christian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WAB Wabtec
$88.87 /

-2.805 (-3.06%)

WAB Wabtec
$88.87 /

-2.805 (-3.06%)

10/20/21 Wells Fargo
Wabtec price target raised to $105 from $95 at Wells Fargo
08/26/21 Citi
Wabtec price target raised to $95 from $88 at Citi
08/19/21 KeyBanc
Wabtec price target raised to $110 from $95 at KeyBanc
03/23/21 Cowen
Wabtec remains positioned to benefit from rail market, says Cowen
WAB Wabtec
$88.87 /

-2.805 (-3.06%)

WAB Wabtec
$88.87 /

-2.805 (-3.06%)

Earnings
Bombardier reports Q3 adjusted EPS (4c), consensus (5c) » 06:21
10/28/21
10/28
06:21
10/28/21
06:21
BDRBF

Bombardier

$1.70 /

-0.05 (-2.86%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDRBF Bombardier
$1.70 /

-0.05 (-2.86%)

BDRBF Bombardier
$1.70 /

-0.05 (-2.86%)

10/15/21 CIBC
Bombardier price target raised to C$1.60 from C$1.30 at CIBC
10/14/21 Desjardins
Bombardier price target raised to C$2.25 from C$1.75 at Desjardins
10/06/21 National Bank
Bombardier price target raised to C$2.50 from C$1.90 at National Bank
09/23/21 Goldman Sachs
Bombardier upgraded to Buy from Neutral at Goldman Sachs
BDRBF Bombardier
$1.70 /

-0.05 (-2.86%)

Initiation
Nio initiated with a Market Perform at Bernstein » 06:21
10/28/21
10/28
06:21
10/28/21
06:21
NIO

Nio

$39.30 /

-1.19 (-2.94%)

Bernstein analyst Eunice…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NIO Nio
$39.30 /

-1.19 (-2.94%)

NIO Nio
$39.30 /

-1.19 (-2.94%)

10/14/21 Nomura
Li Auto initiated with a Buy at Nomura
10/12/21 Mizuho
Mizuho positive on Tesla, Nio shares heading into Q4
10/07/21
Fly Intel: Top five analyst upgrades
10/07/21 Goldman Sachs
Goldman upgrades Nio to Buy on ET7's potential, sees 65% upside
NIO Nio
$39.30 /

-1.19 (-2.94%)

  • 14
    Dec
NIO Nio
$39.30 /

-1.19 (-2.94%)

NIO Nio
$39.30 /

-1.19 (-2.94%)

NIO Nio
$39.30 /

-1.19 (-2.94%)

Recommendations
Thermo Fisher price target raised to $715 from $700 at Citi » 06:20
10/28/21
10/28
06:20
10/28/21
06:20
TMO

Thermo Fisher

$612.36 /

+4.42 (+0.73%)

Citi analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TMO Thermo Fisher
$612.36 /

+4.42 (+0.73%)

TMO Thermo Fisher
$612.36 /

+4.42 (+0.73%)

10/20/21
Fly Intel: Top five analyst upgrades
10/20/21 Citi
Citi upgrades Thermo Fisher to Buy, says discount unwarranted
10/20/21 Citi
Thermo Fisher upgraded to Buy from Neutral at Citi
10/14/21 Cowen
Thermo Fisher price target raised to $696 from $655 at Cowen
TMO Thermo Fisher
$612.36 /

+4.42 (+0.73%)

TMO Thermo Fisher
$612.36 /

+4.42 (+0.73%)

TMO Thermo Fisher
$612.36 /

+4.42 (+0.73%)

Earnings
West Pharmaceutical ups FY21 adjusted EPS view to $8.40-$8.50 from $8.05-$8.20 » 06:20
10/28/21
10/28
06:20
10/28/21
06:20
WST

West Pharmaceutical

$421.86 /

+1.29 (+0.31%)

Consensus $8.21. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WST West Pharmaceutical
$421.86 /

+1.29 (+0.31%)

WST West Pharmaceutical
$421.86 /

+1.29 (+0.31%)

11/09/20 KeyBanc
West Pharmaceutical initiated with an Overweight at KeyBanc
WST West Pharmaceutical
$421.86 /

+1.29 (+0.31%)

Recommendations
Comerica price target raised to $100 from $93 at Citi » 06:20
10/28/21
10/28
06:20
10/28/21
06:20
CMA

Comerica

$84.67 /

-2.955 (-3.37%)

Citi analyst Jill Shea…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMA Comerica
$84.67 /

-2.955 (-3.37%)

10/21/21 RBC Capital
Comerica price target raised to $95 from $91 at RBC Capital
10/21/21 Truist
Comerica price target raised to $98 from $83 at Truist
10/21/21 B. Riley
Comerica price target raised to $87 from $78 at B. Riley
10/11/21 Jefferies
Comerica price target raised to $86 from $75 at Jefferies
CMA Comerica
$84.67 /

-2.955 (-3.37%)

CMA Comerica
$84.67 /

-2.955 (-3.37%)

Periodicals
SoftBank makes $25M investment in OurCrowd in exchange for stake, CNBC reports » 06:19
10/28/21
10/28
06:19
10/28/21
06:19
SFTBY

SoftBank Group

$27.27 /

-0.94 (-3.33%)

Softbank has made a $25M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SFTBY SoftBank Group
$27.27 /

-0.94 (-3.33%)

SFTBY SoftBank Group
$27.27 /

-0.94 (-3.33%)

07/21/21 JPMorgan
SoftBank Group assumed with an Overweight at JPMorgan
06/08/21 Jefferies
SoftBank upgraded to Buy from Hold at Jefferies
04/20/21 Citi
Nvidia deal for Arm has only 10% chance of closing, says Citi
03/11/21 Jefferies
SoftBank downgraded to Hold from Buy at Jefferies
SFTBY SoftBank Group
$27.27 /

-0.94 (-3.33%)

SFTBY SoftBank Group
$27.27 /

-0.94 (-3.33%)

SFTBY SoftBank Group
$27.27 /

-0.94 (-3.33%)

Earnings
WNS Holdings raises FY22 adj EPS view to $3.18-$3.34 from $3.09-$3.28 » 06:19
10/28/21
10/28
06:19
10/28/21
06:19
WNS

WNS Holdings

$84.81 /

-0.195 (-0.23%)

Consensus for FY22 EPS is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WNS WNS Holdings
$84.81 /

-0.195 (-0.23%)

08/17/21 JPMorgan
WNS Holdings price target raised to $99 from $89 at JPMorgan
07/16/21 Cowen
WNS Holdings price target raised to $90 from $82 at Cowen
07/16/21 Barrington
WNS Holdings price target raised to $95 from $84 at Barrington
07/16/21 Deutsche Bank
WNS Holdings price target raised to $85 from $80 at Deutsche Bank
WNS WNS Holdings
$84.81 /

-0.195 (-0.23%)

Recommendations
ServiceNow price target raised to $770 from $746 at Citi » 06:18
10/28/21
10/28
06:18
10/28/21
06:18
NOW

ServiceNow

$664.99 /

-11.99 (-1.77%)

Citi analyst Tyler Radke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOW ServiceNow
$664.99 /

-11.99 (-1.77%)

NOW ServiceNow
$664.99 /

-11.99 (-1.77%)

04:57 Today Jefferies
Jefferies ups ServiceNow target to $765, says buy on weakness
10/22/21 Oppenheimer
ServiceNow price target raised to $775 from $700 at Oppenheimer
10/20/21 BofA
ServiceNow price target raised to $800 from $700 at BofA
10/18/21 Mizuho
ServiceNow price target raised to $680 from $650 at Mizuho
NOW ServiceNow
$664.99 /

-11.99 (-1.77%)

NOW ServiceNow
$664.99 /

-11.99 (-1.77%)

NOW ServiceNow
$664.99 /

-11.99 (-1.77%)

Earnings
West Pharmaceutical reports Q3 adjusted EPS $2.06, consensus $1.80 » 06:17
10/28/21
10/28
06:17
10/28/21
06:17
WST

West Pharmaceutical

$421.86 /

+1.29 (+0.31%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WST West Pharmaceutical
$421.86 /

+1.29 (+0.31%)

WST West Pharmaceutical
$421.86 /

+1.29 (+0.31%)

11/09/20 KeyBanc
West Pharmaceutical initiated with an Overweight at KeyBanc
WST West Pharmaceutical
$421.86 /

+1.29 (+0.31%)

Recommendations
Edwards Lifesciences price target raised to $120 from $113 at Citi » 06:17
10/28/21
10/28
06:17
10/28/21
06:17
EW

Edwards Lifesciences

/

+

Citi analyst Joanne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EW Edwards Lifesciences
/

+

EW Edwards Lifesciences
/

+

09/21/21 Raymond James
Opsens price target raised to C$6.00 from C$2.75 at Raymond James
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
07/30/21 Canaccord
Edwards Lifesciences price target raised to $124 from $103 at Canaccord
07/30/21 Jefferies
Edwards Lifesciences price target raised to $130 from $110 at Jefferies
EW Edwards Lifesciences
/

+

EW Edwards Lifesciences
/

+

EW Edwards Lifesciences
/

+

Downgrade
Teva downgraded to Market Perform from Outperform at Raymond James » 06:17
10/28/21
10/28
06:17
10/28/21
06:17
TEVA

Teva

$8.94 /

-0.475 (-5.05%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TEVA Teva
$8.94 /

-0.475 (-5.05%)

TEVA Teva
$8.94 /

-0.475 (-5.05%)

04:47 Today Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
TEVA Teva
$8.94 /

-0.475 (-5.05%)

TEVA Teva
$8.94 /

-0.475 (-5.05%)

TEVA Teva
$8.94 /

-0.475 (-5.05%)

TEVA Teva
$8.94 /

-0.475 (-5.05%)

Earnings
WNS Holdings reports Q3 EPS 86c, consensus 76c » 06:16
10/28/21
10/28
06:16
10/28/21
06:16
WNS

WNS Holdings

$84.81 /

-0.195 (-0.23%)

Reports Q3 revenue less…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WNS WNS Holdings
$84.81 /

-0.195 (-0.23%)

08/17/21 JPMorgan
WNS Holdings price target raised to $99 from $89 at JPMorgan
07/16/21 Cowen
WNS Holdings price target raised to $90 from $82 at Cowen
07/16/21 Barrington
WNS Holdings price target raised to $95 from $84 at Barrington
07/16/21 Deutsche Bank
WNS Holdings price target raised to $85 from $80 at Deutsche Bank
WNS WNS Holdings
$84.81 /

-0.195 (-0.23%)

Earnings
Summit Financial Group reports Q3 EPS 92c, consensus 82c » 06:16
10/28/21
10/28
06:16
10/28/21
06:16
SMMF

Summit Financial Group

$24.98 /

-0.22 (-0.87%)

Net interest margin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMMF Summit Financial Group
$24.98 /

-0.22 (-0.87%)

07/30/21 Piper Sandler
Summit Financial upgraded to Overweight from Neutral at Piper Sandler
SMMF Summit Financial Group
$24.98 /

-0.22 (-0.87%)

Recommendations
Silgan Holdings price target raised to $45 from $42 at Citi » 06:16
10/28/21
10/28
06:16
10/28/21
06:16
SLGN

Silgan Holdings

$39.88 /

+0.75 (+1.92%)

Citi analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLGN Silgan Holdings
$39.88 /

+0.75 (+1.92%)

SLGN Silgan Holdings
$39.88 /

+0.75 (+1.92%)

10/05/21 Loop Capital
Loop starts Silgan with Buy amid 'meaningful growth' in North America
10/05/21 Loop Capital
Silgan Holdings initiated with a Buy at Loop Capital
10/01/21 JPMorgan
JPMorgan downgrades Silgan to sell on food can demand concerns
10/01/21 JPMorgan
Silgan Holdings downgraded to Underweight from Neutral at JPMorgan
SLGN Silgan Holdings
$39.88 /

+0.75 (+1.92%)

Recommendations
Teladoc price target lowered to $190 from $225 at Citi » 06:15
10/28/21
10/28
06:15
10/28/21
06:15
TDOC

Teladoc

$138.38 /

-2.98 (-2.11%)

Citi analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TDOC Teladoc
$138.38 /

-2.98 (-2.11%)

TDOC Teladoc
$138.38 /

-2.98 (-2.11%)

06:01 Today Piper Sandler
Teladoc price target lowered to $183 from $291 at Piper Sandler
10/18/21 Wells Fargo
Wells Fargo starts telehealth 'one-stop shop' Teladoc at Overweight
09/20/21 KeyBanc
New CEO 'certainly a positive surprise' for NextGen shareholders, says KeyBanc
09/15/21 RBC Capital
Teladoc long-term growth outlook intact, says RBC Capital
TDOC Teladoc
$138.38 /

-2.98 (-2.11%)

TDOC Teladoc
$138.38 /

-2.98 (-2.11%)

TDOC Teladoc
$138.38 /

-2.98 (-2.11%)

TDOC Teladoc
$138.38 /

-2.98 (-2.11%)

Hot Stocks
M.D.C. Holdings sees Q4 home deliveries 2,700-3,000 » 06:15
10/28/21
10/28
06:15
10/28/21
06:15
MDC

M.D.C. Holdings

$50.16 /

-0.11 (-0.22%)

Sees Q4 average selling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDC M.D.C. Holdings
$50.16 /

-0.11 (-0.22%)

MDC M.D.C. Holdings
$50.16 /

-0.11 (-0.22%)

10/14/21 JPMorgan
M.D.C. Holdings downgraded to Neutral with $66 target at JPMorgan
10/14/21 JPMorgan
M.D.C. Holdings downgraded to Neutral from Overweight at JPMorgan
04/15/21 Wells Fargo
M.D.C. Holdings initiated with an Equal Weight at Wells Fargo
03/16/21 Wolfe Research
M.D.C. Holdings initiated with a Peer Perform at Wolfe Research
MDC M.D.C. Holdings
$50.16 /

-0.11 (-0.22%)

MDC M.D.C. Holdings
$50.16 /

-0.11 (-0.22%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.